Fiji Kava bringing products 'from farm to shelf' backed by research and clinical trials

Fiji Kava Ltd (ASX:FIJ) chief executive Zane Yoshida introduces Proactive Investors to the newly-listed company, and explains the history behind as well as market opportunities for kava.

The company aims to bring a range of products "from farm to shelf," supported by strong research and development, and clinical trials with the National Institute of Complementary Medicine.

Taki Mai-branded products are already available for sale online, and Fiji Kava-branded products will be launched in the coming months, available through e-commerce giant Amazon.